IL‐4 and interferon‐γ differentially modulate vascular endothelial growth factor release from normal human keratinocytes and fibroblasts
Authors:
- 1 June 2002
- journal article
- research article
- Published by Wiley in Experimental Dermatology
- Vol. 11 (3) , 224-231
Abstract
IL‐4 and interferon‐γ (IFN‐γ) are crucial modulators of the immune system and are reported as active antitumor agents and potent inhibitors of angiogenesis. We investigated the effects of these two cytokines on the expression of vascular endothelial growth factor (VEGF), a mediator of major importance in the angiogenesis associated with inflammation, wound healing and tumor invasion and expressed by activated keratinocytes and dermal fibroblasts. Human keratinocytes (HK) and fibroblasts (HF) derived from foreskins, were further cultured during 24 h in defined medium, supplemented or not with the selected growth factors, EGF and TGF‐β1, respectively, before receiving the addition of either IL‐4 or IFN‐γ during 24 and 48 h. In basal conditions, fibroblasts produced smaller amounts of VEGF than keratinocytes; the addition of growth factors to the skin cells induced a drastic increase of VEGF secretion. In HF, the basal level of VEGF secretion was reduced by IFN‐γ and slightly increased by IL‐4 whereas in HK, IFN‐γ enhanced the secretion of VEGF after 48 h and IL‐4 either tended to reduce VEGF secretion or did not exert any effect. Similar but more significant results were observed in skin cells activated by growth‐stimulating factors. The association of IL‐4 and IFN‐γ mimicked the effects of IFN‐γ alone both in HF and HK. Taken together, these results indicate opposite effects of IFN‐γ and IL‐4 on VEGF expression from normal and activated HF and HK. IL‐4 may be considered as a poor modulator of VEGF secretion by dermal and epidermal cells. Conversely, IFN‐γ appears as a prominent and versatile mediator in the desregulated angiogenesis associated with inflammatory skin reactions characterized by a T‐helper type 1 cell‐mediated response.Keywords
This publication has 30 references indexed in Scilit:
- Transforming growth factor-beta1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin-1 in human dermal fibroblastsBritish Journal of Dermatology, 2000
- Transforming Growth Factor- beta mRNA and Protein in Hypertrophic Scar Tissues and Fibroblasts: Antagonism by IFN- alpha and IFN- gamma In Vitro and In VivoJournal of Interferon & Cytokine Research, 2000
- Interferon‐γ inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor‐β1 in vitroFEBS Letters, 1999
- EFFECTS OF INTERFERONS ON TUMOUR NECROSIS FACTOR α PRODUCTION FROM HUMAN KERATINOCYTESCytokine, 1998
- Antagonistic Effects of Interferon-γ and Interleukin-4 on Fibroblast Cultures.Journal of Investigative Dermatology, 1997
- Interferon-γ as a regulator of squamous differentiationJournal of Dermatological Science, 1996
- Keratinocyte-Derived Vascular Permeability Factor (Vascular Endothelial Growth Factor) Is a Potent Mitogen for Dermal Microvascular Endothelial CellsJournal of Investigative Dermatology, 1995
- Interaction of Interleukin‐1 and Interferon‐γ on Fibroblast Growth Factor‐induced AngiogenesisJapanese Journal of Cancer Research, 1994
- Interleukin‐4 and interferon‐γ interactions in the induction of intercellular adhesion molecule‐1 and major histocompatibility complex class II antigen expression of normal human keratinocytesExperimental Dermatology, 1994
- Inhibition of Cell Motility by InterferonScience, 1980